BETA DRUGS
Back to Cashflow Statement
|
BETA DRUGS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹118 Cr | ₹9.47 Cr | ₹1.84 Cr | ₹6.90 Cr | ₹5.04 Cr |
What is the latest Net Cash Inflow / Outflow ratio of BETA DRUGS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹118 Cr |
| Mar2024 | ₹9.47 Cr |
| Mar2023 | ₹1.84 Cr |
| Mar2022 | ₹6.90 Cr |
| Mar2021 | ₹5.04 Cr |
How is Net Cash Inflow / Outflow of BETA DRUGS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹118 Cr | 1,150.30 | |
| Mar2024 | ₹9.47 Cr | 414.62 | |
| Mar2023 | ₹1.84 Cr | -73.33 | |
| Mar2022 | ₹6.90 Cr | 36.94 | |
| Mar2021 | ₹5.04 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹2,351.5 Cr | -0.3% | -18.4% | 9.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | -0.3% |
-18.4% |
9.5% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses